BD Active Retraction Safe Vascular Indwelling Needle - Blood Control
Taiwan·Risk Class 2·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Registered Mar 07, 2012 – Mar 07, 2027Active- Analysis ID
- 8d9fd9770c708e1374793e307aa50055
- Customs Code
- DHA00602327309
- Manufacturer
- BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
- Manufacturer Country
- United States
- Authorized Representative
- BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5200 Endovascular catheters
- Import Information
- import
- Registration Date
- Mar 07, 2012
- Expiry Date
- Mar 07, 2027
Access comprehensive regulatory information for BD Active Retraction Safe Vascular Indwelling Needle - Blood Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8d9fd9770c708e1374793e307aa50055 and manufactured by BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.